Suppr超能文献

细胞间相互作用与阿司匹林加重的呼吸道疾病。

Cellular interactions in aspirin-exacerbated respiratory disease.

机构信息

Department of Medicine, University of California San Diego.

Veterans Affairs San Diego Healthcare System, La Jolla, California, USA.

出版信息

Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):65-70. doi: 10.1097/ACI.0000000000000712.

Abstract

PURPOSE OF REVIEW

The purpose of this review is to summarize the complex cellular interactions of aspirin-exacerbated respiratory disease (AERD) and how these interactions promote pathogenic mechanisms of AERD.

RECENT FINDINGS

In addition to characteristic changes in eicosanoid levels, recent studies have identified increases in alarmin cytokines (IL-33, thymic stromal lymphopoietin) as well as activated innate lymphoid and plasma cell populations in samples from AERD patients.

SUMMARY

Patients with AERD typically demonstrate high levels of proinflammatory eicosanoids including cysteinyl leukotrienes (CysLTs) and prostaglandin D2 (PGD2) and hyporesponsiveness to prostaglandin E2 (PGE2). CysLTs are released by mast cells, eosinophils, and adherent platelets and promote epithelial release of IL-33, which activates mast cells and group 2 innate lymphoid cells (ILC2s) in concert with CysLTs. TSLP induces PGD2 release from mast cells which activates and recruits eosinophils, basophils, Th2 cells, and ILC2s via CRTH2. In turn, ILC2s and other cell types produce Th2 cytokines IL-4, IL-5, and IL-13 that, along with CysLTs and PGD2, promote bronchoconstriction, eosinophilic tissue inflammation, and mucus production.

摘要

目的综述

本文旨在总结阿司匹林加重性呼吸系统疾病(AERD)中复杂的细胞间相互作用,以及这些相互作用如何促进 AERD 的发病机制。

最新发现

除了花生四烯酸代谢产物水平的特征性变化外,最近的研究还发现 AERD 患者样本中警报素细胞因子(IL-33、胸腺基质淋巴细胞生成素)和活化的固有淋巴细胞和浆细胞群体增加。

总结

AERD 患者通常表现出高水平的促炎类花生酸,包括半胱氨酰白三烯(CysLTs)和前列腺素 D2(PGD2),并且对前列腺素 E2(PGE2)的反应降低。CysLTs 由肥大细胞、嗜酸性粒细胞和黏附血小板释放,并促进上皮细胞释放 IL-33,与 CysLTs 一起激活肥大细胞和 2 型固有淋巴细胞(ILC2)。TSLP 诱导肥大细胞释放 PGD2,激活并募集嗜酸性粒细胞、嗜碱性粒细胞、Th2 细胞和 ILC2 通过 CRTH2。反过来,ILC2 和其他细胞类型产生 Th2 细胞因子 IL-4、IL-5 和 IL-13,与 CysLTs 和 PGD2 一起促进支气管收缩、嗜酸性粒细胞组织炎症和黏液产生。

相似文献

1
Cellular interactions in aspirin-exacerbated respiratory disease.
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):65-70. doi: 10.1097/ACI.0000000000000712.
2
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2016 May;137(5):1566-1576.e5. doi: 10.1016/j.jaci.2015.10.020. Epub 2015 Dec 12.
3
Association of interleukin-25 levels with development of aspirin induced respiratory diseases.
Respir Med. 2017 Feb;123:71-78. doi: 10.1016/j.rmed.2016.11.020. Epub 2016 Nov 24.
5
Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
J Immunol. 2015 Oct 15;195(8):3537-45. doi: 10.4049/jimmunol.1500905. Epub 2015 Sep 4.
6
Cysteinyl leukotriene E activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D and epithelial cytokines.
J Allergy Clin Immunol. 2017 Oct;140(4):1090-1100.e11. doi: 10.1016/j.jaci.2016.12.958. Epub 2017 Jan 20.
7
Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
J Immunol. 2018 Feb 1;200(3):915-927. doi: 10.4049/jimmunol.1700603. Epub 2017 Dec 27.
8
Role of group 2 innate lymphocytes in aspirin-exacerbated respiratory disease pathogenesis.
Am J Rhinol Allergy. 2018 Jan 1;32(1):7-11. doi: 10.2500/ajra.2018.32.4498.
9
Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2021 Aug;148(2):309-318. doi: 10.1016/j.jaci.2021.06.016.
10
Aspirin-exacerbated respiratory disease.
Curr Opin Immunol. 2020 Oct;66:9-13. doi: 10.1016/j.coi.2020.02.006. Epub 2020 Apr 13.

引用本文的文献

2
Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment.
Front Allergy. 2024 Nov 27;5:1462985. doi: 10.3389/falgy.2024.1462985. eCollection 2024.
3
Cysteinyl Leukotrienes in Allergic Inflammation.
Annu Rev Pathol. 2025 Jan;20(1):115-141. doi: 10.1146/annurev-pathmechdis-111523-023509. Epub 2025 Jan 2.
5
Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD.
J Allergy Clin Immunol. 2023 Nov;152(5):1330-1335.e1. doi: 10.1016/j.jaci.2023.06.028. Epub 2023 Aug 3.
6
Pathomechanisms of AERD-Recent Advances.
Front Allergy. 2021 Sep 10;2:734733. doi: 10.3389/falgy.2021.734733. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验